NewAmsterdam Pharma Company NV (NAMS)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-28 | 2025-03-26 | B Purchase | Non-Executive Director |
1,135
+0.0%
22.49USD 25,521 |
1,135 +0.0% | 22.49 | USD 25,521 | |
| 2025-03-06 | 2025-03-04 | B Purchase | Non-Executive Director |
4,005
+0.1%
21.02USD 84,203 |
4,005 +0.1% | 21.02 | USD 84,203 | |
| 2025-03-05 | 2025-03-04 | S Sale |
Chief Accounting Officer Officer |
150,000
-90.9%
20.37USD 3,055,500 |
150,000 -90.9% | 20.37 | USD 3,055,500 | |
| 2025-01-02 | 2024-12-30 | PS Planned sale | Large shareholder |
29,846
-0.3%
25.54USD 762,174 |
29,846 -0.3% | 25.54 | USD 762,174 | |
| 2024-12-30 | 2024-12-27 | PS Planned sale | Large shareholder |
41,472
-0.4%
25.95USD 1,076,290 |
41,472 -0.4% | 25.95 | USD 1,076,290 | |
| 2024-12-30 | 2024-12-26 | PS Planned sale | Large shareholder |
33,438
-0.3%
26.01USD 869,629 |
33,438 -0.3% | 26.01 | USD 869,629 | |
| 2024-12-26 | 2024-12-24 | PS Planned sale | Large shareholder |
16,164
-0.1%
25.66USD 414,831 |
16,164 -0.1% | 25.66 | USD 414,831 | |
| 2024-12-26 | 2024-12-23 | PS Planned sale | Large shareholder |
25,132
-0.2%
25.49USD 640,625 |
25,132 -0.2% | 25.49 | USD 640,625 | |
| 2024-12-26 | 2024-12-20 | PS Planned sale | Large shareholder |
5,629
-0.1%
26.13USD 147,071 |
5,629 -0.1% | 26.13 | USD 147,071 | |
| 2024-12-26 | 2024-12-20 | PS Planned sale | Large shareholder |
44,143
-0.4%
25.53USD 1,126,993 |
44,143 -0.4% | 25.53 | USD 1,126,993 | |
| 2024-12-20 | 2024-12-19 | PS Planned sale | Large shareholder |
56,506
-0.5%
25.45USD 1,437,806 |
56,506 -0.5% | 25.45 | USD 1,437,806 | |
| 2024-12-20 | 2024-12-18 | PS Planned sale | Large shareholder |
46,210
-0.4%
26.55USD 1,226,857 |
46,210 -0.4% | 26.55 | USD 1,226,857 | |
| 2024-12-20 | 2024-12-18 | PS Planned sale | Large shareholder |
54,518
-0.5%
25.72USD 1,402,050 |
54,518 -0.5% | 25.72 | USD 1,402,050 | |
| 2024-12-18 | 2024-12-17 | PS Planned sale | Large shareholder |
47,736
-0.4%
26.45USD 1,262,441 |
47,736 -0.4% | 26.45 | USD 1,262,441 | |
| 2024-12-18 | 2024-12-17 | PS Planned sale | Large shareholder |
66,648
-0.6%
25.60USD 1,706,315 |
66,648 -0.6% | 25.60 | USD 1,706,315 | |
| 2024-12-18 | 2024-12-16 | PS Planned sale | Large shareholder |
1,096
-0.0%
25.00USD 27,400 |
1,096 -0.0% | 25.00 | USD 27,400 | |
| 2024-12-16 | 2024-12-13 | PS Planned sale | Large shareholder |
25,751
-0.2%
25.01USD 644,048 |
25,751 -0.2% | 25.01 | USD 644,048 | |
| 2024-12-16 | 2024-12-12 | PS Planned sale | Large shareholder |
25,963
-0.2%
26.18USD 679,615 |
25,963 -0.2% | 26.18 | USD 679,615 | |
| 2024-12-16 | 2024-12-12 | PS Planned sale | Large shareholder |
140,048
-1.2%
25.25USD 3,536,212 |
140,048 -1.2% | 25.25 | USD 3,536,212 | |
| 2024-12-12 | 2024-12-11 | PS Planned sale | Large shareholder |
4,894
-0.0%
27.11USD 132,671 |
4,894 -0.0% | 27.11 | USD 132,671 | |
| 2024-12-12 | 2024-12-11 | PS Planned sale | Large shareholder |
18,583
-0.2%
26.41USD 490,684 |
18,583 -0.2% | 26.41 | USD 490,684 | |
| 2024-12-12 | 2024-12-11 | PS Planned sale | Large shareholder |
130,561
-1.1%
25.26USD 3,298,454 |
130,561 -1.1% | 25.26 | USD 3,298,454 | |
| 2024-12-12 | 2024-12-10 | PS Planned sale | Large shareholder |
48,511
-0.4%
26.15USD 1,268,606 |
48,511 -0.4% | 26.15 | USD 1,268,606 | |
| 2024-12-12 | 2024-12-10 | PS Planned sale | Large shareholder |
259,739
-2.2%
25.22USD 6,550,202 |
259,739 -2.2% | 25.22 | USD 6,550,202 | |
| 2024-11-19 | 2024-11-18 | PS Planned sale | Large shareholder |
33,273
-0.3%
25.08USD 834,440 |
33,273 -0.3% | 25.08 | USD 834,440 | |
| 2024-11-19 | 2024-11-15 | PS Planned sale | Large shareholder |
8,530
-0.1%
25.02USD 213,436 |
8,530 -0.1% | 25.02 | USD 213,436 | |
| 2024-11-15 | 2024-11-14 | PS Planned sale | Large shareholder |
9,832
-0.1%
25.01USD 245,856 |
9,832 -0.1% | 25.01 | USD 245,856 | |
| 2024-11-15 | 2024-11-13 | PS Planned sale | Large shareholder |
1,066
-0.0%
25.00USD 26,655 |
1,066 -0.0% | 25.00 | USD 26,655 | |
| 2024-10-01 | 2024-10-01 | S Sale |
Chief Accounting Officer Officer |
45,000
-100.0%
15.72USD 707,400 |
45,000 -100.0% | 15.72 | USD 707,400 | |
| 2024-09-30 | 2024-09-26 | B Purchase |
Chief Business Officer Officer |
1,104
+inf%
15.70USD 17,333 |
1,104 +inf% | 15.70 | USD 17,333 | |
| 2024-08-22 | 2024-08-20 | B Purchase |
Chief Executive Officer Executive Director |
5,000
+2.4%
16.27USD 81,350 |
5,000 +2.4% | 16.27 | USD 81,350 | |
| 2024-06-24 | 2024-06-20 | B Purchase |
Chief Executive Officer Executive Director |
5,000
+2.5%
17.26USD 86,309 |
5,000 +2.5% | 17.26 | USD 86,309 | |
| 2024-03-28 | 2024-03-26 | B Purchase | Non-Executive Director |
8,429
+0.3%
21.50USD 181,224 |
8,429 +0.3% | 21.50 | USD 181,224 | |
| 2024-03-27 | 2024-03-26 | S Sale |
Kastelein Johannes Jacob Pieter Chief Scientific Officer Executive Director |
190,476
-100.0%
21.50USD 4,095,234 |
190,476 -100.0% | 21.50 | USD 4,095,234 | |
| 2024-02-21 | 2024-02-13 | B Purchase | Non-Executive Director |
5,000
+25.2%
19.00USD 95,000 |
5,000 +25.2% | 19.00 | USD 95,000 |